Schonfeld Strategic Advisors »

Theravance Biopharma shares owned by Schonfeld Strategic Advisors

Quarter-by-quarter ownership of Theravance Biopharma (TBPH) shares owned by Schonfeld Strategic Advisors from 13F filings

Historical chart of Schonfeld Strategic Advisors investment in Theravance Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Theravance Biopharma held by Schonfeld Strategic Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Theravance Biopharma by Schonfeld Strategic Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $310k 17k 18.71
2023-09-30 $496k 57k 8.63
2023-06-30 $187k 18k 10.35
2022-12-31 $327k 29k 11.22

More positions owned by Schonfeld Strategic Advisors

Ishares Tr Core S&p500 Etf (IVV)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
NVIDIA Corporation (NVDA)
Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)
Ishares Tr China Lg-cap Etf (FXI)
Microsoft Corporation (MSFT)
Tesla Motors (TSLA)
Amazon (AMZN)
Alphabet Cap Stk Cl C (GOOG)
Ishares Silver Tr Ishares (SLV)
Alphabet Cap Stk Cl A (GOOGL)
Fidelity Wise Origin Bitcoin SHS (FBTC)
Ishares Ethereum Tr SHS (ETHA)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Spdr Series Trust State Street Spd Call Option (KRE)

View all positions for Schonfeld Strategic Advisors

Top funds holding Theravance Biopharma

Madison Avenue Partners
Weiss Asset Management LP[1
Newtyn Management
BlackRock
Irenic Capital Management
Vanguard Group
Park West Asset Management
D. E. Shaw & Co
Acadian Asset Management
State Street Corporation
Arrowstreet Capital, Limited Partnership
Geode Capital Management
Dimensional Fund Advisors
Oasis Management
UBS Group

View all funds holding Theravance Biopharma